The phase 2 multicenter TROPION-PanTumor study was designed to evaluate the efficacy of TROP2-directed antibody-drug conjugate datopotamab deruxtecan (Dato-DXd) as monotherapy and in combination with...
Read moreRESILIENCE is a clinical trial funded by the European Commission (H2020 Programme) that aims to reduce the prevalence of heart failure in cancer survivors
Read moreIt is estimated that in 2024, around 12,400 new cases of lymphoma will be diagnosed in Spain, the majority (approximately 85%) being non-Hodgkin.
Read moreHermenegildo García, investigador del Instituto de Tecnología Química (CSIC-UPV), obtiene una ayuda Advanced Grant del Consejo Europeo de Investigación dotada con 2,5 millones de euros
Read moreUn fármaco que disminuye la producción de glutatión en las células disminuye el crecimiento de un tumor linfático agresivo en un modelo animal.
Read moreLa expresión “somos lo que comemos” se extiende más allá de los nutrientes o calorías: una pequeña parte del microbioma intestinal humano se compone de microorganismos adquiridos a través de...
Read moreNace un proyecto de investigación que quiere impulsar el uso de medusas como una fuente sostenible para el desarrollo de biomateriales en el campo de la biomedicina.
Read moreA pesar de que la reparación artroscópica es el tratamiento habitual, en los casos en los que el tendón es irreparable, las transferencias tendinosas se han convertido en la única alternativa viab...
Read moreBel-sar Demonstrated 80% Tumor Control Rate, 90% Visual Acuity Preservation, and a Highly Favorable Safety Profile
Read moreA study carried out by teams from the University of Barcelona and IDIBELL has described — with a very high degree of detail and one by one — the cells that make up the pancreas and its ducts.
Read moreOne of the key advantages of academia-industry partnerships is the potential for accelerated innovation. By combining the theoretical knowledge of academia with the practical, market-oriented approach...
Read moreThe use of artificial intelligence or an innovative approach focused on measuring NLRP3 inflammasome activation in monocytes ex vivo are examples of the latest advancements against sepsis.
Read more